Pudowik; Aladshewa, Zhurnal Obshchei Khimii, 1958, vol. 28, p. 2497,2499;engl.Ausg.S.2532,2533
作者:Pudowik、Aladshewa
DOI:——
日期:——
[EN] FUSED RING KRAS INHIBITORS FOR TREATING DISEASE<br/>[FR] INHIBITEURS DE KRAS À CYCLES FUSIONNÉS POUR LE TRAITEMENT D'UNE MALADIE
申请人:[en]BLOSSOMHILL THERAPEUTICS, INC.
公开号:WO2024015262A1
公开(公告)日:2024-01-18
The present disclosure relates to fused ring compounds targeting KRAS, pharmaceutical compositions containing the compounds, and methods of using such compounds to treat disease, such as cancer.
A Formal [3,3]-Sigmatropic Rearrangement Route to Quaternary α-Vinyl Amino Acids: Use of Allylic <i>N</i>-PMP Trifluoroacetimidates
作者:David B. Berkowitz、Bin Wu、Huijie Li
DOI:10.1021/ol060019s
日期:2006.3.2
Pd(II)-mediated rearrangement of allylic N-PMP (p-methoxyphenyl) trifluoroacetimidates provides the first formal sigmatropic route to quaternary, alpha-vinylic amino acids, potential suicide substrates for PLP enzymes. The amino acid side chains enter via transition-metal-mediated C-C bond constructions, including (i) Cu(I)-mediated conjugate addition (Ala); (ii) Pd(0)/AsPh3-mediated Stille coupling